FDA Medication Guides – Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) Read more
FDA Guidance Responding to Unsolicited Request for Off-Label Information About Prescription Drugs and Medical Devices Read more
Reductions in Commercial Support for Continuing Medical Education Results in Lower Quality, Harder to Locate and More Expensive CME Read more